Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonists. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Newton, R C
- Bergman, J M
- Veber, D F
- Freedman, S B
- Smith, A J
- Chapman, K L
- Patel, S
- Kemp, J A
Producer: 19950518
In:
Bioorganic & medicinal chemistry vol. 2
Availability: No items available.
|
|
|
8.
|
A uniquely potent renin inhibitor and its unanticipated plasma binding component. [electronic resource] by
- Evans, B E
- Rittle, K E
- Bock, M G
- Bennett, C D
- DiPardo, R M
- Boger, J
- Poe, M
- Ulm, E H
- LaMont, B I
- Blaine, E H
Producer: 19860116
In:
Journal of medicinal chemistry vol. 28
Availability: No items available.
|
|
|
9.
|
Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Evans, B E
- Rittle, K E
- Boger, J
- Poe, M
- LaMont, B I
- Lynch, R J
- Ulm, E H
- Vlasuk, G P
Producer: 19871106
In:
Journal of medicinal chemistry vol. 30
Availability: No items available.
|
|
|
10.
|
Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications. [electronic resource] by
- Freidinger, R M
- Williams, P D
- Tung, R D
- Bock, M G
- Pettibone, D J
- Clineschmidt, B V
- DiPardo, R M
- Erb, J M
- Garsky, V M
- Gould, N P
Producer: 19900806
In:
Journal of medicinal chemistry vol. 33
Availability: No items available.
|
|
|
11.
|
Second-generation benzodiazepine CCK-B antagonists. Development of subnanomolar analogs with selectivity and water solubility. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Mellin, E C
- Newton, R C
- Veber, D F
- Freedman, S B
- Smith, A J
- Patel, S
- Kemp, J A
- Marshall, G R
Producer: 19940504
In:
Journal of medicinal chemistry vol. 37
Availability: No items available.
|
|
|
12.
|
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Rittle, K E
- Evans, B E
- Freidinger, R M
- Veber, D F
- Chang, R S
- Chen, T B
- Keegan, M E
- Lotti, V J
Producer: 19861119
In:
Journal of medicinal chemistry vol. 29
Availability: No items available.
|
|
|
13.
|
Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Evans, B E
- Freidinger, R M
- Rittle, K E
- Payne, L S
- Boger, J
- Whitter, W L
- LaMont, B I
- Ulm, E H
Producer: 19881118
In:
Journal of medicinal chemistry vol. 31
Availability: No items available.
|
|
|
14.
|
Renin inhibitors containing 2-substituted statine. [electronic resource] by
- Veber, D F
- Bock, M G
- Brady, S F
- Ulm, E H
- Cochran, D W
- Smith, G M
- LaMont, B I
- Dipardo, R M
- Poe, M
- Freidinger, R M
Producer: 19850510
In:
Biochemical Society transactions vol. 12
Availability: No items available.
|
|
|
15.
|
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists. [electronic resource] by
- DiPardo, R M
- Patane, M A
- Newton, R C
- Price, R
- Broten, T P
- Chang, R S
- Ransom, R W
- Di Salvo, J
- Freidinger, R M
- Bock, M G
Producer: 20010927
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
|
16.
|
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists. [electronic resource] by
- Evans, B E
- Rittle, K E
- Bock, M G
- DiPardo, R M
- Freidinger, R M
- Whitter, W L
- Gould, N P
- Lundell, G F
- Homnick, C F
- Veber, D F
Producer: 19870807
In:
Journal of medicinal chemistry vol. 30
Availability: No items available.
|
|
|
17.
|
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Evans, B E
- Rittle, K E
- Whitter, W L
- Veber, D F
- Freidinger, R M
- Chang, R S
- Chen, T B
- Lotti, V J
Producer: 19900222
In:
Journal of medicinal chemistry vol. 33
Availability: No items available.
|
|
|
18.
|
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. [electronic resource] by
- Evans, B E
- Rittle, K E
- Bock, M G
- DiPardo, R M
- Freidinger, R M
- Whitter, W L
- Lundell, G F
- Veber, D F
- Anderson, P S
- Chang, R S
Producer: 19890112
In:
Journal of medicinal chemistry vol. 31
Availability: No items available.
|
|
|
19.
|
Orally active, nonpeptide oxytocin antagonists. [electronic resource] by
- Evans, B E
- Leighton, J L
- Rittle, K E
- Gilbert, K F
- Lundell, G F
- Gould, N P
- Hobbs, D W
- DiPardo, R M
- Veber, D F
- Pettibone, D J
Producer: 19921127
In:
Journal of medicinal chemistry vol. 35
Availability: No items available.
|
|
|
20.
|
Development of 1,4-benzodiazepine cholecystokinin type B antagonists. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Evans, B E
- Rittle, K E
- Whitter, W L
- Garsky, V M
- Gilbert, K F
- Leighton, J L
- Carson, K L
- Mellin, E C
Producer: 19940204
In:
Journal of medicinal chemistry vol. 36
Availability: No items available.
|